000 01451 a2200373 4500
005 20250516045129.0
264 0 _c20120413
008 201204s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-10-0872
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWatson, Venita Gresham
245 0 0 _aGenomic profiling in CEPH cell lines distinguishes between the camptothecins and indenoisoquinolines.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cOct 2011
300 _a1839-45 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aCamptothecin
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aGene Expression Profiling
650 0 4 _aGenomics
_xmethods
650 0 4 _aHumans
650 0 4 _aIsoquinolines
_xpharmacology
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aQuantitative Trait Loci
650 0 4 _aTopoisomerase I Inhibitors
_xpharmacology
700 1 _aHardison, Nicholas E
700 1 _aHarris, Tyndall
700 1 _aMotsinger-Reif, Alison
700 1 _aMcLeod, Howard L
773 0 _tMolecular cancer therapeutics
_gvol. 10
_gno. 10
_gp. 1839-45
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-10-0872
_zAvailable from publisher's website
999 _c21001047
_d21001047